All Infection Prevention & Control articles – Page 34
-
NewsResearchers demonstrate SARS-CoV-2 virus inactivation/destruction using focused sound waves
A team of researchers has successfully demonstrated the destruction of SARS-CoV-2 virus particles through exposure to high-frequency sound waves, marking a promising advance in non-pharmacological antiviral strategies.
-
NewsCOVID-19 viral fragments shown to target and kill specific immune cells
New research shows that after the body’s defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 spike protein can target specific immune cells based on their shape. It could explain why certain populations of cells that detect and fight infection are depleted in patients with severe COVID-19.
-
NewsNative fungi from almond orchards show promise as sustainable defenders against a devastating crop disease
Researchers report that naturally occurring fungi found on and within almond trees can strongly suppress Colletotrichum godetiae, the primary cause of almond anthracnose in the Mediterranean Basin.
-
News‘Nudging’ both patients and providers boosts flu vaccine numbers
Patients were 28 per cent more likely to get a flu shot when they got a text message reminder and their primary care provider already had an order for the shot waiting, new research showed.
-
NewsAntibiotic therapy: is shorter just as effective?
Shorter-duration antibiotic therapy shows comparable success to longer-duration treatment in children with community-acquired pneumonia. However, a general conclusion about a shortened treatment duration is not possible, Tthe authors of a new study say.
-
NewsScientists develop novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. Source: NIAID-RML This colorized transmission electron microscope image shows ...
-
News3′UTR-derived small RNA couples acid resistance to metabolic reprogramming in Salmonella within macrophages
Salmonella expresses the arginine decarboxylase AdiA, which confers acid resistance by catalyzing an H+-consuming reaction. Researchers have discovered that the 3′-untranslated region (UTR) of adiA mRNA is processed by RNase E into a regulatory small RNA, AdiZ.
-
NewsDouble trouble: Tobacco use and Long COVID
Researchers investigating the relationship between Long Covid symptoms and smoking by tobacco type found that certain symptoms correlated with different forms of smoking.
-
NewsStudent focused on pathogens says new award has opened a door to span aquaculture and ecology
A University of Stirling student who is the latest recipient of the Nikos Steiropoulos Aquaculture Scholarship from MSD Animal Health UK says the award has helped to “open a door she could only have dreamed of”.
-
NewsStudy identifies blood protein albumin as key defense against deadly fungal infection ‘mucormycosis’
A new study has identified albumin as a powerful and previously unrecognized defense against a rare but often fatal fungal infection. Patients with mucormycosis had markedly lower levels of albumin compared with patients suffering from other fungal infections.
-
NewsNexaBiome accelerates development of novel diabetic foot treatment with Scottish Enterprise funding
UK biotechnology company NexaBiome Life Sciences Ltd has received continued funding from Scotland’s national economic development agency, Scottish Enterprise, to accelerate its breakthrough bacteriophage technology for the treatment of diabetic foot infections (DFIs).
-
NewsLow vitamin D levels shown to raise risk of hospitalization with potentially fatal respiratory tract infections by 33%
Severe vitamin D deficiency is associated with a higher rate of hospitalisation for respiratory tract infections such as bronchitis and pneumonia. Scientists found that those with a severe deficiency (below 15 nnmol/L) were 33 per cent more likely to be admitted to hospital for treatment.
-
NewsMajor clinical trial provides definitive evidence of impacts of steroid treatment on severe brain infection
A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis, caused by herpes simplex virus (HSV) does not improve long-term outcomes overall, although early use may lead to better recovery.
-
NewsScientists discover novel immune ‘traffic controller’ hijacked by virus
Researchers have discovered a tissue protein that acts as a central ‘traffic controller’ for immune cells and can be hijacked by a virus to weaken immune responses. Cytomegalovirus (CMV) can hijack this system by producing a protein that blocks CD44 function on stromal cells.
-
NewsMost would recommend RSV immunizations for older and pregnant people
A US survey found an increase in awareness of immunizations that are available for RSV. The survey of 1,637 U.S. adults also found that about 6 in 10 respondents would recommend the vaccine or antibody injections to the groups recommended by the CDC, an increase from past years.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsEarly translational study supports the role of high-dose inhaled nitric oxide as a potential antimicrobial therapy
Researchers report that high-dose inhaled nitric oxide (iNO) demonstrates potential antimicrobial activity in preclinical models and is safe and feasible in early human studies, supporting further clinical investigation.
-
NewsEngineered nanobodies improved respiratory defenses in preclinical study
Engineered nanobodies improved protection against multiple viruses by bolstering respiratory mucus. The bispecific design of the nanobodies works against viruses, like influenza, which can normally evade mucosal defenses.
-
NewsNew study shows how light suppresses virulence in antibiotic-resistant pathogen
Researchers uncover a light-sensitive signaling cascade in Pseudomonas aeruginosa that suppresses biofilm formation and virulence, offering a potential new strategy to combat antibiotic-resistant infections.
-
NewsGlobal Virus Network warns of measles resurgence
The Global Virus Network (GVN) has expressed deep concern regarding the ongoing resurgence of measles in the United States and around the globe. Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children.